Dr. Golob is a physician scientist with both extensive clinical and research training. He has a background in engineering (Computer Science and Biomedical engineering) and is an enthusiastic teacher of the computational analysis of data. His first bench laboratory research involved gene therapy (adenoviral, AAV, and early lentiviral vectors) and stem cell (mesenchymal and hematopoietic) biology. His doctoral work was in the role of epigenetics in the differentiation of pluripotent stem cells. This worked involved some of the earliest next-generation sequencing and de-novo analysis software design. His post-doctoral research involved the gut microbiome during hematopoietic stem cell transplant. Jonathan first started clinical medicine by training as an emergency medical technician with the Baltimore City Fire Department. He is an infectious disease specialist, further specialized in the care of people with immune dysfunction (with cancer, post-transplant, and others) and infections. He was involved in the University of Michigan response to the COVID-19 pandemic, both providing some of the earliest direct patient care (as an infectious disease specialist) and clinical research (controlled observational studies and randomized clinical trials for novel COVID-19 therapeutics). Dr. Golob was born in the Detroit area. After a brief stint in Baltimore City, he spent nearly twenty years in Seattle, WA. While in Seattle, he wrote a science column for the local alt-weekly The Stranger. He is an avid traveler (pre COVID-19), cheerful home baker (also pre-COVID-19), father, and enjoys the outdoors (particularly cross country skiing in the winter). He enjoys working with, learning from, and mentoring fellow scientists.